Lo Andrew 4
4 · BridgeBio Pharma, Inc. · Filed May 6, 2025
Insider Transaction Report
Form 4
Lo Andrew
Director
Transactions
- Sale
Common Stock
2025-05-02$38.50/sh−100,000$3,849,900→ 105,583 total(indirect: By Andrew W. Lo and Nancy N. Lo JTWROS)
Holdings
- 48,099
Common Stock
Footnotes (1)
- [F1]Represents the weighted average sale price of the shares sold from $38.155 to $38.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.